Last reviewed: June 16, 2026
Last updated: June 16, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Men pursuing testosterone replacement therapy (TRT) often face an unexpected challenge: weight gain that becomes harder to manage over time. When GLP-1 medications like semaglutide enter the picture, questions about safety and compatibility naturally arise. The good news is that combining these therapies is generally considered safe when properly monitored by qualified healthcare providers.
How Semaglutide and TRT Work in the Body
Semaglutide activates glucagon-like peptide-1 receptors throughout the digestive system and brain, signaling fullness, slowing stomach emptying, and reducing appetite. This mechanism operates independently of testosterone's effects on muscle tissue, bone density, and metabolic rate. The two medications target completely different physiological pathways, which is why they don't directly interact at the cellular level.
Testosterone replacement increases lean muscle mass, bone mineral density, and basal metabolic rate through androgen receptor activation in target tissues. Unlike GLP-1 therapy, TRT doesn't significantly affect appetite regulation or glucose metabolism in the short term. When used together, they create a dual benefit: TRT preserves and builds muscle while semaglutide reduces caloric intake and body fat accumulation.
Clinical Considerations for Combined GLP-1 and TRT Therapy
Research on simultaneous GLP-1 and testosterone use remains limited, but existing data from men on both treatments shows no major safety red flags when dosing is appropriate and monitoring occurs regularly. A key concern involves ensuring weight loss from semaglutide doesn't outpace muscle preservation efforts from TRT, potentially leading to muscle loss rather than pure fat reduction. Healthcare providers typically recommend maintaining adequate protein intake and resistance training to maximize the synergistic benefits of both therapies.
Blood sugar control and metabolic markers require closer attention in men on TRT, as testosterone can subtly influence insulin sensitivity. Semaglutide improves glucose metabolism, which may actually provide a protective metabolic benefit. Baseline testing of fasting glucose, HbA1c, and lipid panels before starting combined therapy helps establish whether additional monitoring intervals are needed during treatment.
Monitoring Requirements When Using Both Treatments
Men combining semaglutide with TRT should schedule hormone and metabolic bloodwork every 8–12 weeks during the first year to track testosterone levels, glucose metabolism, lipid profiles, and kidney function markers. Semaglutide is cleared by the kidneys, so patients with existing renal concerns require more frequent assessment. This enhanced monitoring ensures both medications remain in therapeutic ranges and that no unexpected interactions are emerging.
Body composition changes—specifically muscle versus fat loss—are best tracked through periodic DEXA scans, bioimpedance analysis, or skilled clinical assessment rather than scale weight alone. A man losing 20 pounds could be losing 15 pounds of fat and 5 pounds of muscle, or 18 pounds of fat and 2 pounds of muscle; the ratio matters enormously for long-term metabolic health. Providers using PlexusDx can leverage patient-specific genetic insights from the Precision Peptide Genetic Test to anticipate individual responses to GLP-1 therapy and adjust TRT dosing strategies accordingly.
PlexusDx Semaglutide as a Practical Option for TRT Patients
PlexusDx compounded semaglutide injections start at $149 per month and are produced by licensed 503A compounding pharmacies, offering a consistent, cost-effective alternative to brand-name options. No insurance is required, no membership fee applies, and the medication is HSA/FSA eligible, making it accessible for men already managing the expense of TRT. The flat-rate pricing means your dose can increase if needed without increasing your monthly cost—a critical feature for men titrating up to effective weight loss levels.
Men on TRT can add the PlexusDx Precision Peptide Genetic Test ($99 add-on after the first month) to understand their unique peptide pathway function. This test maps 14 metabolic pathways, 49 peptide-related genes, and 150+ genetic insights, including variants in GLP1R, GIPR, FTO, and MC4R genes that predict individual semaglutide response. This personalized data helps optimize dosing speed and identify whether alternative formulations—such as oral semaglutide or tirzepatide—might yield better results for a specific patient.
Practical Steps to Safely Combine These Therapies
Start by discussing your TRT regimen in detail with the healthcare provider overseeing your weight loss therapy. Share current testosterone doses, injection schedules, baseline lab values, and any prior metabolic concerns. Ensure your TRT provider is also informed that you're beginning GLP-1 therapy so both teams can coordinate monitoring and adjust treatment plans if needed. Clear communication between providers prevents duplicate testing, conflicting advice, and missed opportunities for dose optimization.
Prioritize protein intake—aim for 0.8–1.0 grams per pound of target body weight daily—to protect muscle during weight loss phases of semaglutide therapy. Combine both medications with progressive resistance training at least 3–4 days per week and maintain consistent sleep, stress management, and hydration. These lifestyle factors amplify the benefits of both TRT and semaglutide while minimizing the risk of adverse metabolic shifts, ensuring you preserve lean tissue while shedding excess fat.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is it safe to take semaglutide if I'm already on TRT?
Yes, semaglutide and testosterone replacement operate on separate metabolic pathways and are generally safe to use together. Enhanced monitoring of hormones, glucose, and kidney function every 8–12 weeks is recommended to ensure both therapies remain optimized and no unexpected interactions occur.
Will semaglutide interfere with testosterone absorption or effectiveness?
No direct pharmacological interaction exists between semaglutide and testosterone. However, semaglutide may slow gastric emptying, which could marginally delay absorption of oral testosterone (if used), though injectable testosterone—the most common TRT delivery method—bypasses the digestive system entirely and remains unaffected.
Can I lose muscle while taking both TRT and semaglutide?
Yes, muscle loss is possible if caloric deficit is too aggressive or protein intake is insufficient, even with TRT onboard. To minimize muscle loss, maintain high protein intake (0.8–1.0 g per pound of target body weight), perform resistance training 3–4 days weekly, and work with your provider to titrate semaglutide gradually rather than jump to high doses immediately.
How much does PlexusDx semaglutide cost compared to Ozempic?
PlexusDx compounded semaglutide injections start at $149 per month with flat pricing across all dose levels—your dose can increase without increasing your cost. Brand-name Ozempic typically costs more and requires insurance or patient assistance programs. PlexusDx requires no insurance, no membership, and is HSA/FSA eligible.
How can the Precision Peptide Genetic Test help me with combined TRT and GLP-1 therapy?
The Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes to predict your individual response to semaglutide and other weight loss therapies. This $99 add-on test (available after your first month of treatment) helps your provider personalize your dose escalation schedule and choose the most effective formulation—semaglutide injection, oral semaglutide, tirzepatide, or combination therapies—based on your genetic profile.
Will semaglutide affect my testosterone levels?
Semaglutide does not directly suppress or enhance testosterone production. However, weight loss itself can improve insulin sensitivity and metabolic health, which may indirectly support stable testosterone levels. Regular lab monitoring of total and free testosterone every 8–12 weeks helps ensure your TRT dose remains appropriate as your body composition changes.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Therapeutic Doses of Tirzepatide for Effective Weight Management
Can You Exercise on Ozempic? Exploring the Synergy Between Medication and Movement